Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Influenza A H1N1 HA (A/California/04/2009) His-tag Recombinant Protein

Catalog No. PIRP88192
Encompass
Click to view available options
Quantity:
100 μg

Recombinant Protein

It is recommended that the protein be aliquoted for optimal storage. It is recommended that sterile water (400 μL) be added to the vial to prepare a stock solution of 0.25 mg/mL. Concentration is measured by UV.

Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.
TRUSTED_SUSTAINABILITY

Specifications

For Use With (Application) Control
Format Lyophilized
Formulation 20 mM tris with <0.1 μg/mL BSA, 0.01% mannitol, 0.01% Tween 80, 10% glycerol, 150 mM NaCl, 5-8% trehalose and no preservative; pH 7.5
Molecular Weight (g/mol) 58.7 kDa
Name Influenza A H1N1 HA (A/California/04/2009) His-tag
Purification Method SDS-PAGE
Quantity 100 μg
Regulatory Status RUO
Endotoxin Concentration <1.0 EU/μg
Gene Alias flu hemagglutinin; H1N1 HA; H1N1 hemagglutinin; Influenza H1N1; influenza hemagglutinin
Common Name Influenza A H1N1 HA
Product Type Protein
Conjugate Unconjugated
Recombinant Recombinant
Protein Tag His-tag
Sequence Influenza A virus H1N1 (A/California/04/2009) hemagglutinin, amino acids His36-Lys469 (Accession # ACP41107.1) with an N-terminal a vasodilator-stimulated phosphoprotein tetramerization domain and a C-terminal His-tag
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Expression System Baculovirus
Form Lyophilized
Purity or Quality Grade >90% as determined by SDS-PAGE.
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.